Macrocyclic peptides active against the hepatitis C virus
US7642235B2 · kind B2 · utility
13Cited by
24References
59Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 20, 2004 |
| Grant date | Jan 5, 2010 |
| Priority date | — |
| Expiry date | Oct 29, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula I:wherein D, R4, R3, L0, L1, L2, R2 and RC are defined herein; or a pharmaceutically acceptable salt thereof, useful as inhibitors of the HCV NS3 protease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.